548 Episodio

  1. Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease

    Pubblicato: 05/02/2020
  2. Delivering Oligonucleotide Therapies to Any Cell Type

    Pubblicato: 29/01/2020
  3. Protalix Looks Beyond Biobetters

    Pubblicato: 22/01/2020
  4. Driving N-of-1 Therapies for Ultra-Rare Disease Patients

    Pubblicato: 15/01/2020
  5. Cutting the Time and Cost of Drug Discovery with MicroOrgans

    Pubblicato: 08/01/2020
  6. Acquisition Combines Two Pipelines for Rare Skin Diseases

    Pubblicato: 02/01/2020
  7. Programming Cells to Produce Neuroprotective Factors to Treat ALS

    Pubblicato: 26/12/2019
  8. Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition

    Pubblicato: 18/12/2019
  9. Developing a Common Language for Rare Diseases

    Pubblicato: 11/12/2019
  10. Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence

    Pubblicato: 04/12/2019
  11. How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients

    Pubblicato: 27/11/2019
  12. Addressing the Barriers to Accessing Experimental Therapies

    Pubblicato: 20/11/2019
  13. A Journey to Advocacy

    Pubblicato: 13/11/2019
  14. Turning Chronic Illness into a Fashion Statement

    Pubblicato: 06/11/2019
  15. Connecting Young Adults with Rare and Chronic Conditions

    Pubblicato: 30/10/2019
  16. Helping Caregivers Care for Themselves

    Pubblicato: 23/10/2019
  17. A Festival of Moving Pictures

    Pubblicato: 16/10/2019
  18. Deep Genomics Boasts an AI First in Drug Discovery

    Pubblicato: 09/10/2019
  19. How to Live with a Disability with Your Mojo Intact

    Pubblicato: 03/10/2019
  20. Why a Big Pharma Exec Embraced Rare Neurological Diseases

    Pubblicato: 25/09/2019

15 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site